Showing 1841 to 1860 of 3449 bills
| Bill Title | Introduced | Latest Action |
|---|---|---|
|
SB 602
(Hawaii - 2022 Regular Session)
Relating To Pharmacy Benefit Managers. |
Jan 22 2021 |
Carried Over To 2022 Regular Session.
Dec 10 2021 |
|
HB 978
(Hawaii - 2022 Regular Session)
Relating To The Medicaid Sustainability Program. |
Jan 25 2021 |
Carried Over To 2022 Regular Session.
Dec 10 2021 |
|
HB 1134
(Hawaii - 2022 Regular Session)
Relating To Pharmacy Audits. |
Jan 26 2021 |
Carried Over To 2022 Regular Session.
Dec 10 2021 |
|
HB 17
(Hawaii - 2022 Regular Session)
Relating To Prescription Drugs. |
Jan 20 2021 |
Carried Over To 2022 Regular Session.
Dec 10 2021 |
|
HB 944
(Hawaii - 2022 Regular Session)
Relating To The Regulatory Authority Of The Insurance Commissioner. |
Jan 25 2021 |
Carried Over To 2022 Regular Session.
Dec 10 2021 |
|
HB 942
(Hawaii - 2022 Regular Session)
Relating To Insurance. |
Jan 25 2021 |
Carried Over To 2022 Regular Session.
Dec 10 2021 |
|
HR 6101
(United States - 117th Congress)
Drug Price Transparency in Medicaid Act of 2021 |
Dec 01 2021 |
Referred To The Subcommittee On Health.
Dec 02 2021 |
|
SB 957
(Pennsylvania - 2021-2022 Regular Session)
An Act amending the act of May 17, 1921 (P.L.682, No.284), known as The Insurance Company Law of 1921, in casualty insurance, providing for insulin coverage. |
Nov 23 2021 |
Pn 1248 Referred To Banking And Insurance
Nov 23 2021 |
|
H 3787
(Massachusetts - 192nd Legislature (2021-2022))
An Act relative to pharmacy benefit managers reimbursements to pharmacies in the Commonwealth |
May 20 2021 |
Accompanied S771
Nov 17 2021 |
|
S 804
(Massachusetts - 192nd Legislature (2021-2022))
An Act to promote transparency and prevent price gouging of pharmaceutical drug prices |
Mar 29 2021 |
Accompanied S771
Nov 17 2021 |
|
H 1254
(Massachusetts - 192nd Legislature (2021-2022))
An Act relative to promoting comprehensive transparency in the pharmaceutical industry |
Mar 29 2021 |
Accompanied S771
Nov 17 2021 |
|
S 736
(Massachusetts - 192nd Legislature (2021-2022))
An Act relative to promoting comprehensive transparency in the pharmaceutical industry |
Mar 29 2021 |
Accompanied S771
Nov 17 2021 |
|
H 729
(Massachusetts - 192nd Legislature (2021-2022))
An Act to ensure prescription drug cost transparency and affordability |
Mar 29 2021 |
Accompanied S771
Nov 17 2021 |
|
S 4132
(New Jersey - 2020-2021 Regular Session)
"New Jersey Pharmacy Benefits Manager Licensure and Regulation Act." |
Nov 12 2021 |
Introduced In The Senate, Referred To Senate Commerce Committee
Nov 12 2021 |
|
A 277
(New Jersey - 2020-2021 Regular Session)
Requires public members of Drug Utilization Review Board to disclose financial interests and benefits received from and investment interests held in pharmaceutical distributors, pharmaceutical manufacturers, or pharmacy benefits managers.* |
Jan 14 2020 |
Approved P.L.2021, C.285.
Nov 08 2021 |
|
S 249
(New Jersey - 2020-2021 Regular Session)
Requires pharmacy benefits manager providing services within Medicaid program to disclose certain information to DHS. |
Jan 14 2020 |
Approved P.L.2021, C.257.
Nov 08 2021 |
|
HB 219
(Delaware - 151st General Assembly (2021-2022))
An Act To Amend Title 18 Of The Delaware Code Relating To Pharmacy Benefits Managers. |
Jun 03 2021 |
Enact W/O Sign By Governor
Oct 26 2021 |
|
HR 19
(United States - 117th Congress)
Lower Costs, More Cures Act of 2021 |
Apr 21 2021 |
Referred To The Subcommittee On Antitrust, Commercial, And Administrative Law.
Oct 19 2021 |
|
HB 1064
(Arkansas - 2021 Regular Session)
To Promote Price Transparency In Reimbursement Of Hospitals By Insurers; To Establish The Disclosure Of Reimbursement Rates For Hospitals Act; And To Require Disclosure By An Insurer Of Reimbursement Rates For Hospitals. |
Dec 31 2020 |
Died In House Committee At Sine Die Adjournment
Oct 15 2021 |
|
HB 451
(Ohio - 134th Legislature (2021-2022))
Revise physician-administered drug law |
Oct 12 2021 |
Refer To Committee
Oct 13 2021 |
Showing 1841 to 1860 of 3449 bills
